Hear Her aims to raise awareness of pregnancy-related deaths and provide support and education to pregnant women and postpartum women (within 1 year of delivery).
About 700 women die each year in the United States as a result of pregnancy-related complications. American Indian/Alaska Native and Black women are 2-3 times more likely to die from pregnancy-related complications than white women1.
The Centers for Disease Control and Prevention (CDC) launched a new campaign, Hear Her, to raise awareness of pregnancy-related deaths and provide support and education to pregnant women and postpartum women (within 1 year of delivery)2.
The campaign highlights the importance of speaking up when something does not feel right, and for everyone she turns to for support to listen carefully and act on her concerns.
“This seminal campaign is intended to disrupt the too-familiar pattern of of preventable maternal mortality and encourage everyone in a woman’s life to be attentive and supportive of her health during this important time,” said CDC Director Robert R. Redfield, MD in a recent press release.
Hear Her features compelling personal stories from women who experienced severe pregnancy-related complications.
It also features a page for providers with actionable steps they can take to reduce pregnancy-related deaths in their patients, which includes:
For more provider resources, view this resourceful page.
The campaign is supported through a partnership with the CDC Foundation and by funding from Merck through its Merck for Mothers program.
__
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Nipocalimab shows promise in preventing hemolytic disease of the fetus and newborn
August 21st 2024The investigational drug could prevent the rare fetal disease HDFN (hemolytic disease of the fetus and newborn) by stopping harmful antibodies from transferring through the placenta during pregnancy.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Nipocalimab shows promise in preventing hemolytic disease of the fetus and newborn
August 21st 2024The investigational drug could prevent the rare fetal disease HDFN (hemolytic disease of the fetus and newborn) by stopping harmful antibodies from transferring through the placenta during pregnancy.
Read More
2 Commerce Drive
Cranbury, NJ 08512